Jump Financial, LLC Novo Cure LTD Transaction History

Jump Financial, LLC

$4.56 Billion
Q3 2024

A detailed history of Jump Financial, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Jump Financial, LLC holds 137,146 shares of NVCR stock, worth $4.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

137,146

Previous 111,360 23.16%

Holding current value

$4.4 Million

Previous $1.91 Million 12.38%

% of portfolio

0.05%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.61 - $23.34 $402,519 - $601,845	25,786 Added 23.16%	137,146 $2.14 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $11,806 - $24,001	-998 Reduced 0.89%	111,360 $1.91 Million
Q1 2024 May 13, 2024	BUY	$12.42 - $17.29 $108,476 - $151,010	8,734 Added 8.43%	112,358 $1.76 Million
Q4 2023 Oct 21, 2024	BUY	$11.13 - $15.78 $733,522 - $1.04 Million	65,905 Added 174.73%	103,624 $1.55 Million
Q4 2023 Feb 07, 2024	BUY	$11.13 - $15.78 $1.15 Million - $1.64 Million	103,624 New	103,624 $1.55 Million
Q1 2023 Oct 21, 2024	SELL	$56.44 - $118.81 $4.16 Million - $8.75 Million	-73,641 Reduced 66.13%	37,719 $2.27 Million
Q1 2023 May 03, 2023	BUY	$56.44 - $118.81 $2.13 Million - $4.48 Million	37,719 New	37,719 $2.27 Million
Q3 2022 Nov 07, 2022	BUY	$67.99 - $89.57 $1.13 Million - $1.49 Million	16,622 New	16,622 $1.26 Million
Q2 2022 Aug 09, 2022	SELL	$56.6 - $89.9 $2.6 Million - $4.14 Million	-46,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$60.15 - $84.52 $2.22 Million - $3.12 Million	36,876 Added 404.16%	46,000 $3.81 Million
Q4 2021 Feb 10, 2022	SELL	$75.08 - $121.99 $1.34 Million - $2.18 Million	-17,876 Reduced 66.21%	9,124 $685,000
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $3.14 Million - $5.25 Million	27,000 New	27,000 $3.14 Million
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $1.23 Million - $2.13 Million	-9,436 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $518,283 - $794,149	4,176 Added 79.39%	9,436 $1.25 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $200,542 - $311,362	1,788 Added 51.5%	5,260 $910,000
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $201,549 - $386,468	3,472 New	3,472 $386,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account

Jump Financial, LLC Novo Cure LTD Transaction History